This site is intended for healthcare professionals
FDA Hero Banner - Multi-coloured pills and tablets
FDA Drug information

CARBON DIOXIDE

Read time: 1 mins
Marketing start date: 29 Apr 2024
...
 

Summary of product characteristics


Effective Time

20231004

Version

10

Spl Product Data Elements

CARBON DIOXIDE CARBON DIOXIDE CARBON DIOXIDE CARBON DIOXIDE

Application Number

NDA205764

Brand Name

CARBON DIOXIDE

Generic Name

CARBON DIOXIDE

Product Ndc

10167-500

Product Type

HUMAN PRESCRIPTION DRUG

Route

RESPIRATORY (INHALATION)

Package Label Principal Display Panel

CARBON DIOXIDE USP Product Label CARBON DIOXIDE USP UN 1013 RX ONLY E15 A AIR SOURCE INDUSTRIES, INC. 3976 CHERRY AVE., LONG BEACH, CA 90807 In CA (800) 295-427 (562) 426-4017 NON-FLAMMABLR GAS 2 AS-6 WARNING: Administration of Carcon Dioxide may be hazardous or contraindicated. For Use only by or under the supervision of a licensed practitioner who is experienced in the use and administration of Carbon Dioxide and is familiar with the indications, effects, dosages, methods, and frequency and duration of administration, and with the hazards, contraindications and side effects, and the precautions to be taken. WARNING: CONTAINS GAS UNDER PRESSURE: MAY EXPLODE IF HEATED. MAY DISPLACE OXYGEN AND CAUSE RAPID SUFFOCATION. Do not handle until all safety precautions have been read and understood. Use and store only outdoors or in a well-ventilated place. Use a back flow preventive device in the piping. Use only with equipment rated for cylinder pressure. Close valve after each use and when empty. Protect from sunlight when ambient temperature exceeds 52°C (125°F). Read and follow the Safety Data Sheet (SDS) before use. FIRST AID: IF INHALED: Remove person to fresh air and keep comfortable for breathing. Get medical advice/attention. CAS 124-38-9 DO NOT REMOVE THIS PRODUCT LABEL AirSource Carbon Dioxide sl

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.